74 results
Page 2 of 4
6-K
EX-99.2
btworbie157 5f
3 Aug 20
Consolidated Financial Statements
12:00am
6-K
EX-99.2
lapbikhx68vfk9kw
31 Jul 20
Condensed Consolidated Interim Financial Statements
9:14pm
6-K
EX-99.2
niv08y1
27 Nov 19
Condensed Consolidated Interim Financial Statements
5:09pm
6-K
EX-99.1
9kdt2s3eb8gid5c2jd73
6 Nov 19
Notice of Annual General and Special Meeting of Shareholders
12:00am
6-K
EX-99.2
phj78623b
23 Aug 19
Condensed Consolidated Interim Financial Statements
3:47pm
6-K
EX-99.2
y7nie73cm
30 May 19
Condensed Consolidated Interim Financial Statements
4:20pm
6-K
EX-99.1
vvfngkoq msm
22 Jan 19
Current report (foreign)
4:43pm
6-K
EX-99.2
j7znmiwwx15
26 Nov 18
Current report (foreign)
4:20pm
6-K
EX-99.2
eoxx56brl3qpqgiy7p
30 May 18
Condensed Consolidated Interim Financial Statements
12:00am
20-F/A
ql2c g2zu
12 Jan 18
Annual report (foreign) (amended)
12:00am
6-K
EX-99.1
d9jwoqbeah 72kp09jru
20 Apr 16
RepliCel Life Sciences Finishes Enrolment for its Tendon Repair and Skin Rejuvenation Clinical Trials
12:00am
6-K
EX-99.2
pdoemqf288cg9cx
26 Nov 14
Condensed Consolidated Interim Financial Statements
12:00am
6-K
EX-99.1
4v9gvw3n
9 Sep 14
Replicel Life Sciences Inc. 6-K
12:00am
6-K
EX-99.2
qbxsxxosns5 n7rldllu
26 Aug 14
Condensed Consolidated Interim Financial Statements
12:00am
6-K
EX-99.1
v0qfos ip
18 Jun 14
RepliCel Life Sciences Announces Closing of Third and Final Tranche of
12:00am